Yutaka Kirino

Dr. Yutaka Kirino


Research Focus & Metrics

Academic Career Length

29Years (1998-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
4 February 2022 in Journal of Neuroscience
Verified
Journal Article
Open access
PDF file
KMKen Matsuura
Ken Matsuura
SKShizuka Kobayashi
Shizuka Kobayashi
KKKohtarou Konno
Kohtarou Konno
MYMiwako Yamasaki
Miwako Yamasaki
THTakahiro Horiuchi
Takahiro Horiuchi
TATetsu Akiyama
Tetsu Akiyama
Signal-induced proliferation-associated 1 (SIPA1)-like 1 (SIPA1L1; also known as SPAR1) has been proposed to regulate synaptic functions that are important in maintaining normal neuronal activities, such as regulating spine growth and synaptic scaling, as a component of the PSD-95/NMDA-R-complex. However, its physiological role remains poorly understood. Here, we performed expression analyses using super-resolution microscopy (SRM) in mouse brain and demonstrated that SIPA1L1 is mainly localized to general submembranous regions in neurons, but surprisingly, not to PSD. Our screening for physiological interactors of SIPA1L1 in mouse brain identified spinophilin and neurabin-1, regulators of G-protein-coupled receptor (GPCR) signaling, but rejected PSD-95/NMDA-R-complex components. Furthermore,Sipa1l1−/−mice showed normal spine size distribution and NMDA-R-dependent synaptic plasticity. Nevertheless,Sipa1l1−/−mice showed aberrant responses to α2-adrenergic receptor (a spinophilin target) or adenosine A1 receptor (a neurabin-1 target) agonist stimulation, and striking behavioral anomalies, such as hyperactivity, enhanced anxiety, learning impairments, social interaction deficits, and enhanced epileptic seizure susceptibility. Male mice were used for all experiments. Our findings revealed unexpected properties of SIPA1L1, suggesting a possible association of SIPA1L1 deficiency with neuropsychiatric disorders related to dysregulated GPCR signaling, such as epilepsy, attention deficit hyperactivity disorder (ADHD), autism, or fragile X syndrome (FXS).SIGNIFICANCE STATEMENTSignal-induced proliferation-associated 1 (SIPA1)-like 1 (SIPA1L1) is thought to regulate essential synaptic functions as a component of the PSD-95/NMDA-R-complex. In our screening for physiological SIPA1L1-interactors, we identified G-protein-coupled receptor (GPCR)-signaling regulators. Moreover, SIPA1L1 knock-out (KO) mice showed striking behavioral anomalies, which may be relevant to GPCR signaling. Our findings revealed an unexpected role of SIPA1L1, which may open new avenues for research on neuropsychiatric disorders that involve dysregulated GPCR signaling. Another important aspect of this paper is that we showed effective methods for checking PSD association and identifying native protein interactors that are difficult to solubilize. These results may serve as a caution for future claims about interacting proteins and PSD proteins, which could eventually save time and resources for researchers and avoid confusion in the field.

21 January 2004 in Journal of Neurobiology
Verified
Journal Article
Closed access
PDF file
MMMasayoshi Murakami
Masayoshi Murakami
SWSatoshi Watanabe
Satoshi Watanabe
TITsuyoshi Inoue
Tsuyoshi Inoue
YKYutaka Kirino
Yutaka Kirino

1 October 1998 in The Journal of Biochemistry
Verified
Journal Article
Closed access
PDF file
DLDong-Seok Lee
Dong-Seok Lee
KAKazunori Anzai
Kazunori Anzai
NHNaohide Hirashima
Naohide Hirashima
YKYutaka Kirino
Yutaka Kirino
The phospholipid translocation from the outer to the inner leaflet of synaptic vesicles isolated from the electric organ of the Japanese electric ray, Narke japonica, was measured using fluorescent phospholipid probes. Phosphatidylcholine (PC), phosphatidylethanolamine (PE), or phosphatidylserine (PS) with a fluorescent NBD-labeled short acyl chain at the sn-2 position was mixed with purified synaptic vesicles and the probe in the outer leaflet of the membranes was reduced with dithionite to quench the fluorescence from time to time. The percentage of fluorescence remaining after the dithionite treatment served as an index for the phospholipid translocation. The results obtained indicated that about 30, 13, and 9% of NBD-PE, NBD-PS, and NBD-PC, respectively, were translocated from the outer to the inner leaflet in 3 h. Thus, the translocation activity in synaptic vesicle membranes was much higher for PE than for PS, in contrast to the previous results obtained with plasma membranes, including synaptosomal membranes. The percentages of the phospholipid in the inner leaflet at equilibrium were estimated to be 41, 31, and 14% for PE, PS, and PC, respectively. The translocation was inhibited by pretreatment with an SH reagent, iodoacetamide, indicating the involvement of a proteinaceous translocator. These data may provide a biochemical basis for elucidating the mechanisms of membrane fusion and exocytosis at nerve endings.


1 November 1998 in IUBMB Life
Verified
Journal Article
Open access
PDF file
YHYutaka Hirakura
Yutaka Hirakura
YSYasushi Satoh
Yasushi Satoh
NHNaohide Hirashima
Naohide Hirashima
TSToshiharu Suzuki
Toshiharu Suzuki
BKBruce L. Kagan
Bruce L. Kagan
YKYutaka Kirino
Yutaka Kirino
The β‐amyloid peptide (βAP) is a major proteinaceous component of senile plaques and cerebrovascular amyloid deposits found in the brain of patients with Alzheimer's disease. βAP is reported to be neurotoxic only when it forms β‐sheet structure and aggregates. In the present study, we report that the neurotoxic core of βAP, βAP‐25‐35 (β25‐35), perturbs liposome membranes, induces membrane current, and exhibits hemolytic activity only in a buffer condition where the peptide forms β‐sheet structure and spontaneously aggregates. In contrast, β25‐35 in its monomeric random coil structure does not perturb lipid membranes significantly, and exhibits no hemolytic activity. Also, the membrane current was inhibited by Congo Red. The ability of β25‐35 to interact with membranes highly correlates with its neurotoxicity reported previously. These results suggest that membrane perturbation by aggregated β25‐35 constitutes the molecular basis of the peptide's neurotoxicity.

1 June 2021 in Research in Social and Administrative Pharmacy
Verified
Journal Article
Closed access
EOEri Ohara
Eri Ohara
YBYoshinori Bando
Yoshinori Bando
TYTomoji Yoshida
Tomoji Yoshida
MOMasaki Ohara
Masaki Ohara
YKYutaka Kirino
Yutaka Kirino
NINaomi Iihara
Naomi Iihara